Table 2.
Hospital survival-related variables.
| Variables | All Patients (n = 51) |
Survivors (n = 32) |
Non-Survivors (n = 19) |
p-Value |
|---|---|---|---|---|
| ECMO Duration (days) | 7 (4–14) | 7 (5–12) | 6 (2–15) | 0.54 |
| Hospital Stay (days) | 27 (12–40) | 34 (28–54) | 7 (2–17) | <0.01 |
| Weaned off ECMO/recovery | 17 (33) | 16 (50) | 1 (5) | <0.01 |
| LVAD Assist | 7 (13) | 5 (16) | 2 (11) | 0.61 |
| Heart transplant | 11 (22) | 11 (34) | 0 | <0.01 |
| BARC III bleeding event | 17 (33) | 8 (25) | 9 (47) | 0.10 |
| Acute Limb Ischemia | 8 (16) | 3 (9) | 5 (26) | 0.11 |
| Scarpa Infection | 5 (10) | 4 (13) | 1 (5) | 0.40 |
| Acute Pulmonary Edema | 16 (31) | 7 (22) | 9 (47) | 0.06 |
| Renal replacement therapy | 12 (23) | 4 (12) | 8 (42) | 0.01 |
| Left ventricle thrombus | 6 (12) | 0 (0) | 6 (32) | <0.01 |
| Harlequin syndrome | 4 (8) | 0 (0) | 4 (21) | 0.02 |
| Switch from peripheral to Central ECMO | 2 (4) | 0 | 2 (10) | 0.04 |
| Massive Hemolysis | 0 | 0 | 0 |
Values expressed as median (25th and 75th percentiles) or as n (%), p-values are provided for comparisons between survivors and non-survivors. LVAD, Left Ventricular Assist Device; BARC, Bleeding Academy Research Consensus.